 INDIANAPOLIS, Sept. 07, 2021 GLOBE NEWSWIRE -- POINT Biopharma Global Inc. NASDAQ: PNT the Company or POINT, a company accelerating the discovery, development and global access to life changing radiopharmaceuticals, today announced that the Companys Chief Executive Officer, Dr. Joe McCann will present at the H.C. Wainwright 23rd Annual Global Investment Conference, being held from September 13-15, 2021. 